Finding the 'sweet spot' in value-based contracts.

Health systems pursing value-based contracts should address six important considerations: The definition of value. Contracting goals. Cost of implementation.

Evaluation of D-ribose pharmacokinetics, dose proportionality, food effect, and pharmacodynamics after oral solution administration in healthy male and female subjects.

This was a double blind, randomized, crossover study of three periods evaluating pharmacokinetics and pharmacodynamics in 12 healthy, adult subjects after administration of D-ribose powder for oral solution, 2.5, 5.0, and 10.